The accurate determination of the risk of cancer recurrence is a critical unmet need in managing thyroid cancer (TC). Although numerous studies have successfully demonstrated the use of high throughput molecular diagnostics in TC prediction, it has not been successfully applied in routine clinical use, particularly in Chinese patients. In our study, we objective to screen for characteristic genes specific to PTC and establish an accurate model for diagnosis and prognostic evaluation of PTC. We screen the differentially expressed genes by Python 3.6 in The Cancer Genome Atlas (TCGA) database. We discovered a three-gene signature Gap junction protein beta 4 (GJB4), Ripply transcriptional repressor 3 (RIPPLY3), and Adrenoceptor alpha 1B (ADRA1B) that had a statistically significant difference. Then we used Gene Expression Omnibus (GEO) database to establish a diagnostic and prognostic model to verify the three-gene signature. For experimental validation, immunohistochemistry in tissue microarrays showed that thyroid samples' proteins expressed by this three-gene are differentially expressed. Our protocol discovered a robust three-gene signature that can distinguish prognosis, which will have daily clinical application.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966665PMC
http://dx.doi.org/10.3389/fmolb.2022.807931DOI Listing

Publication Analysis

Top Keywords

three-gene signature
12
differentially expressed
8
identification 3-gene
4
3-gene prognostic
4
prognostic papillary
4
papillary thyroid
4
thyroid carcinoma
4
carcinoma accurate
4
accurate determination
4
determination risk
4

Similar Publications

Qualitative Transcriptional Signature for Predicting the Pathological Response of Colorectal Cancer to FOLFIRI Therapy.

Int J Mol Sci

November 2024

Fujian Key Laboratory of Medical Bioinformatics, Department of Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350122, China.

FOLFIRI (5-FU, leucovorin, irinotecan) is the first-line chemotherapy for metastatic colorectal cancer (mCRC), but response rates are under 50%. This study aimed to develop a predictive signature for FOLFIRI response in mCRC patients. Firstly, Spearman's rank correlation and Wilcoxon rank-sum test were used to select chemotherapy response genes and gene pairs, respectively.

View Article and Find Full Text PDF

Tuberculosis (TB) is a major global health threat and demands improved diagnostic and treatment monitoring methods. Conventional diagnostics, such as sputum smear microscopy and culture, are limited by slow results and low sensitivity, particularly in certain patient groups. Recent advances in biomarker research offer promising solutions in three key areas: risk of disease, diagnosis of active disease and monitoring of treatment response.

View Article and Find Full Text PDF

Background: Necroptosis, a form of programmed inflammatory cell death, plays a crucial role in tumor development, necrosis, metastasis, and immune response. This study aimed to explore the role of necroptosis in BLCA and construct a new prognostic model to guide clinical treatment and predict individualized treatment response.

Methods: The transcriptome profiling and the corresponding clinical data of BLCA patients were obtained from the Cancer Genome Atlas database (TCGA) and GEO databases.

View Article and Find Full Text PDF
Article Synopsis
  • * By analyzing data from major cancer databases like GEO and TCGA, researchers identified 111 genes related to resistance to therapies, developed a risk score model, and validated key proteins associated with patient survival.
  • * The findings highlight crucial hub genes (NNAT, IGFBP6, CYGB) and a prognostic nomogram that can help personalize treatment strategies, ultimately aiming to enhance prognostic predictions for GBM patients.
View Article and Find Full Text PDF
Article Synopsis
  • - Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic pain condition with unclear causes, which leads to lower urinary tract issues and has shown inconsistent treatment results due to its complex nature.
  • - Researchers created a mouse model of IC/BPS using specific chemicals and tested the effects of artesunate (ART), finding significant symptom relief and histological improvements, alongside identifying key gene modules related to the condition.
  • - The study reveals changes in immune cells related to IC/BPS and represents a pioneering approach using single-cell transcriptomics to understand the immune environment, suggesting ART's potential therapeutic role, although further patient-focused studies are necessary.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!